Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Ciattarelli cleared to sue Sherrill over opioid claims as New Jersey race tightens ahead of Election Day
Supreme Court to hear pivotal case challenging Trump's tariffs, with small businesses bearing the brunt and the president potentially making a historic appearance.
Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Ciattarelli cleared to sue Sherrill over opioid claims as New Jersey race tightens ahead of Election Day
Supreme Court to hear pivotal case challenging Trump's tariffs, with small businesses bearing the brunt and the president potentially making a historic appearance.
